您的购物车当前为空
ONL-1204 is a small molecule, CD95 antigen inhibitor (Fas inhibitor) being developed by ONL Therapeutics for the treatment of retinal detachment.

ONL-1204 is a small molecule, CD95 antigen inhibitor (Fas inhibitor) being developed by ONL Therapeutics for the treatment of retinal detachment.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 | |
| 100 mg | 待询 | 10-14周 |
ONL-1204 相关产品
| 产品描述 | ONL-1204 is a small molecule, CD95 antigen inhibitor (Fas inhibitor) being developed by ONL Therapeutics for the treatment of retinal detachment. |
| 分子量 | 1461.66 |
| 分子式 | C71H100N18O16 |
| CAS No. | 2040964-58-5 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容